Ligand Pharmaceuticals | LGND - Ebitda





Ebitda Alterar Data
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.8B 1.25B 2026-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Baxter International USD 474M 165M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Enviri Corporation USD 70.13M 4.29M 2025-12
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -80.97M 93.7M 2026-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Pacira USD 50.45M 1.78M 2026-09
Pfizer USD 6.36B 350M 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 41.24M 2.72M 2026-09